Ultime notizie per Legend Biotech (NASDAQ:LEGN) Azioni

LEGEND BIOTECH CORP-ADR

Legend Biotech

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Legend Biotech Corporation - American Depositary Shares

Legend Biotech Corp

HC Wainwright &amp; Co. analyst Swayampakula Ramakanth maintains Delcath Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DCTH#NASDAQ">DCTH</a>) with a Buy and raises the price target from $24 to $29.

News

Price Target

Analyst Ratings

DCTH

HC Wainwright & Co. Maintains Buy on Delcath Systems, Raises Price Target to $29

OTLK

Outlook Therapeutics Prices $13M Public Offering Of Stock And Warrants At $1.40 Per Unit; Proceeds To Support Working Capital Needs

Net proceeds from the Transaction will be directed towards debt repayment to accelerate deleveraging efforts and strengthen Vermilion's balance sheet. Based on current strip commodity pricing(1) and operational plans, we would expect to exit 2025 with net debt(2) of $1.5&nbsp;billion, with a trailing net debt to FFO ratio(3) of 1.4&nbsp;times.

Vermilion Energy To Sell Saskatchewan And Manitoba Assets For $415M, Accelerate Debt Repayment

Lyondellbasell Declared Quarterly Dividend Of $1.37 Per Share, Representing $0.03 Per Share Increase Over Q1 Dividend; It Will Be Paid To Shareholders On June 9, 2025, With An Ex-dividend

Offerings

Gamehaus Holdings Filed Prospectus For Resale Of Up To 52.1M Class A Shares By Selling Shareholders

Modiv Says It Provided Clarity On Reverse Stock Split Proposal, Company Plans To Eliminate Dormant Accounts, And Cut Administrative Costs

Eason Technology Limited ("Eason Technology" or the "Company") (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DXF#NYSE">DXF</a>) today announced that it received a notice from NYSE Regulation indicating that the Company is not in compliance with the continued listing standards of NYSE American LLC ("NYSE American" or the "Exchange"). The Company failed to timely file its Form 20-F for the period ended December 31, 2024 (the "2024 Form 20-F") by the filing due date of May 15, 2025 (the "Filing Delinquency"). The Company is now subject to the procedures and requirements set forth in Section 1007 of the NYSE American Company Guide.
As disclosed in the Form 12b-25 filed by the Company on April 30, 2025, the Company was unable, without unreasonable effort or expense, to file its 2024 Form 20-F as a result of a delay in completing its financial statements for the period ended December 31, 2024. The Company was not able to make the required filing by May 15, 2025. The Company is making all efforts to file the 2024 Form 20-F as soon as possible and within the Initial Cure Period. However, there can be no assurance that the Company will ultimately regain compliance with all applicable Exchange listing standards.
This delinquency notice has no immediate impact on the listing of the Company's ADSs, which will continue to be listed and traded on the NYSE American during the cure period subject to continued compliance with the other listing requirements of the NYSE American.

Eason Technology Receives NYSE Non-Compliance Notice Following Delayed Filing of 2024 Form 20-F

<a href="https://www.reuters.com/world/us/us-panel-divided-over-nippon-steel-bid-us-steel-path-forward-seen-says-official-2025-05-22/" title="https://www.reuters.com/world/us/us-panel-divided-over-nippon-steel-bid-us-steel-path-forward-seen-says-official-2025-05-22/">https://www.reuters.com/world/us/us-panel-divided-over-nippon-steel-bid-us-steel-path-forward-seen-says-official-2025-05-22/</a>

Reuters Reported Earlier, National Security Panel Divided On Nippon Steel's Bid For U.S. Steel; Majority Say Risks Can Be Addressed, Citing White House Official

Benchmark analyst David Williams maintains Analog Devices (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADI#NASDAQ">ADI</a>) with a Buy and lowers the price target from $275 to $260.

Benchmark Maintains Buy on Analog Devices, Lowers Price Target to $260

The Donald Trump administration is making plans that could set the stage for deep-sea mining off the coast of American Samoa.
The move comes after an executive order from President Donald Trump aimed at quickening access to critical seabed resources in the interest of national security and economic development.
What Happened: On Tuesday, the Interior Department announced plans to begin a formal inquiry to assess industry and public interest in seabed mineral extraction near American Samoa, a U.S. territory in the South Pacific. According <a href="https://thehill.com/policy/energy-environment/5311881-trump-deep-sea-mining-american-samoa/">to</a> The Hill, this preliminary step, called a &#8220;request for information and interest," is meant to collect feedback from stakeholders like mining companies and the Indigenous Island community.
Interior Secretary Doug Burgum said, "By providing opportunities to responsibly access deep-sea mineral resources, we are supporting both <a href="https://www.benzinga.com/markets/25/04/45005825/us-has-tons-of-solutions-to-secure-rare-earth-production-if-china-halts-exports-experts-say-but-warn-of-significant-challenges">American economic growth</a> and national security."
See Also: <a href="https://www.benzinga.com/news/large-cap/25/05/45573883/walmart-cuts-1500-corporate-jobs-to-streamline-operations-amid-tariff-pressures">Walmart Cuts 1,500 Corporate Jobs To Streamline Operations Amid Tariff Pressures</a>
Why It Matters: According to the World Resources Institute, the aim of deep-sea mining is to "retrieve valuable mineral deposits found on the ocean&#8217;s floor, hundreds or even thousands of meters below its surface." The depths of the sea are home to a diverse range of marine life and contain "significant reserves of copper, cobalt, nickel, zinc, silver, gold, and rare earth elements."
While deep-sea mining <a href="https://www.benzinga.com/25/04/44835160/trump-orders-critical-minerals-probe-as-china-tightens-controls-over-rare-commodities">could reduce U.S. dependence on foreign supply chains</a>, environmental advocates warn that the practice may cause lasting ecological damage, including toxic sediment plumes, noise pollution, and irreversible harm to fragile marine ecosystems.
According to the World Wildlife Fund, only 1.1% of the knowledge needed to make science-based decisions about whether deep-seabed mining can go ahead is currently available.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/tech/25/05/45581375/microsoft-executive-says-companies-might-be-naming-ai-chiefs-but-they-risk-losing-momentum-in-the-artificial-intelligence-age-if-they-rely-on-individuals">Microsoft Executive Says Companies Might Be Naming &#8216;AI Chiefs&#8217; But They Risk Losing Momentum In The Artificial Intelligence Age If They Rely On Individuals</a></li>
</ul>
Photo courtesy: Joey Sussman / Shutterstock.com

Politics

Trump Administration Eyes Deep-Sea Mining Near American Samoa Amid Push For Critical Minerals

Keybanc analyst Ashley Owens downgrades Deckers Outdoor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DECK#NYSE">DECK</a>) from Overweight to Sector Weight.

Downgrades

DECK

Keybanc Downgrades Deckers Outdoor to Sector Weight

The Federal Trade Commission has launched an investigation into Media Matters for America, escalating scrutiny over alleged coordination with watchdog groups to orchestrate advertiser boycotts against Elon Musk's social platform, X. What Happened: The FTC issued a civil investigative demand seeking documents related to Media Matters&#8217; communications with other organizations that monitor misinformation and hate speech, including the Global Alliance for Responsible Media, an initiative under the World Federation of Advertisers, reported Reuters, citing documents. 
Both groups are currently facing lawsuits from X.
The probe focuses on whether Media Matters helped facilitate ad pullbacks after Musk acquired Twitter (now X) in 2022. The watchdog has denied wrongdoing, calling the FTC's actions politically motivated, according to the report.
FTC Chairman Andrew Ferguson, a President Donald Trump appointee, signaled in December that the agency would pursue "unlawful collusion" between online platforms and advertisers. The House Judiciary Committee previously accused the Global Alliance of organizing an illegal group boycott. That initiative was dissolved in 2023.
See Also: <a href="https://www.benzinga.com/markets/25/05/45582003/jamie-dimon-who-once-said-trump-was-right-about-some-of-china-now-reportedly-appears-to-be-siding-with-xi-jinping-amid-washington-beijing-tensions">Jamie Dimon, Who Once Said Trump Was &#8216;Right About Some Of China,&#8217; Now Reportedly Appears To Be Siding With Xi Jinping Amid Washington-Beijing Tensions</a>
Why It Matters: The FTC's inquiry coincides with X&#8217;s expanded <a href="https://www.benzinga.com/tech/25/02/43420490/elon-musks-x-bolsters-antitrust-lawsuit-with-additional-advertisers">antitrust lawsuit against major advertisers</a> — including Nestlé, Abbott, and Colgate-Palmolive, alleging coordinated efforts to suppress ad spending. The outcome could set new precedents for how advertisers and platforms interact.
Media Matters President Angelo Carusone said, &#8220;These threats won&#8217;t work; we remain steadfast to our mission.&#8221; Meanwhile, concerns over platform bias persist: visibility for several X users dropped after they publicly criticized Musk, prompting <a href="https://www.benzinga.com/general/social-media/25/04/44973207/elon-musks-critics-on-x-see-sudden-drop-in-visibility-raising-questions-about-platforms-free-speech-commitments">questions over free speech enforcement</a>. 
Ad revenue on X is expected to rebound in 2025, but remains below pre-Musk levels, per Emarketer, the report noted. 
Image Via Shutterstock 
Read Also:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/global/25/05/45582741/g7-targets-chinas-state-driven-trade-tactics-without-naming-it-pledging-action-against-nonmarket-practices">G7 Targets China&#8217;s State-Driven Trade Tactics Without Naming It, Pledging Action Against &#8216;Nonmarket Practices&#8217;</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Regulations

Social Media

Legal

Elon Musk's X Sparks FTC Probe Into Media Matters Over Ad Boycott Coordination With Watchdog Groups: Report

Earnings

MNSO

CORRECTION: MINISO Group Q1 EPS $0.26 Down From $0.27 YoY, Sales $610.06M Miss $624.52M Estimate. Earlier Headline Misstated Quarter As Q3

Wedbush analyst Daniel Ives maintains Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) with a Outperform and raises the price target from $350 to $500.

TSLA

Wedbush Maintains Outperform on Tesla, Raises Price Target to $500

Needham analyst Scott Berg reiterates Workday (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDAY#NASDAQ">WDAY</a>) with a Buy and maintains $300 price target.

Reiteration

WDAY

Needham Reiterates Buy on Workday, Maintains $300 Price Target

A post on Reddit&#8217;s r/WallStreetBets community is making waves after a user claimed to have made a bold, high-conviction stock play, risking not just financial ruin, but putting his marriage on the line.
What Happened: Friday early morning, a WallStreetBets user who goes by the name /u/Sensitive_Reveal_227 <a href="https://www.reddit.com/r/wallstreetbets/comments/1kt8b8d/i_took_100k_from_our_house_sale_and_bought_303/">posted</a> details surrounding his huge bet in the community.
He claims to have sold his house, clearing $120,000 in equity, of which he invested $100,000 into 303 shares of beleaguered health insurer, UnitedHealth Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>), all of which he did without informing his wife, and even outright misleading her.
&#8220;Wife said, ‘Put it somewhere safe.' I said, hold my beer,&#8221; he says, &#8220;Then funneled $100K into Fidelity and bought 303 shares of UnitedHealth.&#8221;
See Also: <a href="https://www.benzinga.com/markets/25/05/45582003/jamie-dimon-who-once-said-trump-was-right-about-some-of-china-now-reportedly-appears-to-be-siding-with-xi-jinping-amid-washington-beijing-tensions">Jamie Dimon, Who Once Said Trump Was &#8216;Right About Some Of China,&#8217; Now Reportedly Appears To Be Siding With Xi Jinping Amid Washington-Beijing Tensions</a>
While this would be a red flag in any marriage, the user insists he technically didn't lie. &#8220;Told the wife the money is safe in a high-yield savings account,&#8221; he added, &#8220;Technically not wrong.&#8221;
The thesis behind his investment is pretty straightforward: America's chronic health problems aren&#8217;t going away anytime soon. &#8220;Fat, old, diabetic, stressed out&#8230; healthcare is the last thing people cut,&#8221; he says, before noting the company&#8217;s scale and robust fundamentals.
The user also highlights recent insider buying in the stock, with the CEO, CFO, and independent directors all <a href="https://benzinga.com/general/health-care/25/05/45486314/unitedhealth-ceo-other-insiders-buy-millions-in-stock-as-it-sinks-over-23-in-a-week-move-gets-mixed-reaction">buying millions worth of shares</a> in the company, with their own personal money, which he views as a bullish signal.
The post concludes with a cheeky note on the user&#8217;s marital gamble, &#8220;Now I just need to convince her to stall on the purchase of our next home&#8230; Till death do us part,&#8221; he adds.
Why It Matters: UnitedHealth has found itself at the center of a perfect storm in recent months, starting <a href="https://www.benzinga.com/general/health-care/24/12/42316904/unitedhealthcare-ceo-brian-thompson-fatally-shot-outside-nyc-hotel">with the assassination</a> of its CEO Brian Thompson in December, which is now the subject of an investor lawsuit that alleges that the company downplayed the potential impact of this murder.
The company&#8217;s CEO, Andrew Witty, <a href="https://www.benzinga.com/25/05/45373368/unitedhealth-stock-plunges-names-new-ceo-suspends-2025-guidance">resigned abruptly last week</a>, further fueling uncertainty among investors, following which the current CEO, Stephen Hemsley, decided to suspend its full-year guidance. 
To top it off, just a few days later, a Wall Street Journal report claimed that UnitedHealth was <a href="https://benzinga.com/general/health-care/25/05/45424904/unitedhealth-stock-caught-in-a-perfect-storm-falls-nearly-50-since-april">under criminal investigation</a> by the U.S. Department of Justice, with a focus on the company&#8217;s Medicare Advantage business practices.
The company refuted all allegations, telling Benzinga that it has not been notified of any supposed criminal investigation by the DOJ, while calling WSJ&#8217;s reporting &#8220;deeply irresponsible.&#8221;
The stock has been on a steady decline since its disappointing first quarter results last month, down nearly 50% since then, despite a rebound this week, following news of <a href="https://benzinga.com/general/health-care/25/05/45486314/unitedhealth-ceo-other-insiders-buy-millions-in-stock-as-it-sinks-over-23-in-a-week-move-gets-mixed-reaction">insider buying activity</a>.
Price Action: The stock was down 2.08% on Thursday, trading at $296.67, but is up 1.33% after hours. It is down 41.20% on a year-to-date basis.
Since we&#8217;re talking about /r/WallStreetBets, it&#8217;s worth noting that GameStop Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>) was up 10.02% on Thursday, due to rising Bitcoin prices, and is up 2.56% after hours.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"><img loading="lazy" decoding="async" width="1024" height="140" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23044556/Screenshot-2025-05-23-at-2.15.44-PM-1024x140.png" alt="" class="wp-image-925615" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23044556/Screenshot-2025-05-23-at-2.15.44-PM-1024x140.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23044556/Screenshot-2025-05-23-at-2.15.44-PM-300x41.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23044556/Screenshot-2025-05-23-at-2.15.44-PM-768x105.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23044556/Screenshot-2025-05-23-at-2.15.44-PM-1536x210.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23044556/Screenshot-2025-05-23-at-2.15.44-PM.png 1594w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
UnitedHealth scores poorly across the board in Benzinga&#8217;s Edge Stock Rankings. Click <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">here</a> for deeper insights into the stock, its peers, and competitors.
Read More:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45582025/stock-market-is-underpricing-downside-risks-of-the-tariff-rates-warns-expert-tariff-policy-nuances-are-far-more-important-than-the-one-big-beautiful-bill">Stock Market Is Underpricing &#8216;Downside Risks Of The Tariff Rates,&#8217; Warns Expert: Tariff Policy Nuances Are &#8216;Far More Important&#8217; Than The &#8216;One Big, Beautiful Bill&#8217;</a></li>
</ul>
Photo courtesy: Piotr Swat / Shutterstock.com

Health Care

Markets

WallStreetBets Redditor Says He Dropped $100K Into UnitedHealth After Selling His House Without Telling His Wife: 'Hold My Beer'

Renowned tech bull Dan Ives has significantly raised his price target for Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) to $500, signaling a strong bullish outlook driven by the imminent arrival of what he terms the &#8220;golden age of autonomous&#8221; vehicles.
What Happened: Ives conveyed his updated stance via an X post, emphasizing the pivotal role of upcoming developments for the electric vehicle giant.
&#8220;We believe the golden age of autonomous is now on the doorstep for Tesla with the Austin launch next month kicking off this key next chapter of growth for Musk &amp; Co.,&#8221; stated Ives.
His revised price target reflects an anticipation of substantial future value creation for the company. &#8220;we are raising our price target to $500 reflecting this massive stage of valuation creation ahead,&#8221; Ives added, underscoring the profound impact he expects autonomous technology to have on Tesla&#8217;s market capitalization.
The price target for the company stood at $350 per share before the update, thus representing a 42.85% increase.
The &#8220;Austin launch&#8221; next month appears to be a key catalyst in Ives&#8217; assessment, suggesting that the expansion of Tesla&#8217;s autonomous capabilities and related initiatives from its Austin facility will be a major driver of this new growth phase for Elon Musk&#8216;s enterprise.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">We believe the golden age of autonomous is now on the doorstep for Tesla with the Austin launch next month kicking off this key next chapter of growth for Musk &amp; Co. and we are raising our price target to $500 reflecting this massive stage of valuation creation ahead. &#x1f525;&#x1f3c6;&#x1f402;&#x1f37f;&#x1f3c5;
&mdash; Dan Ives (@DivesTech) <a href="https://twitter.com/DivesTech/status/1925841823282393561?ref_src=twsrc%5Etfw">May 23, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/25/05/45582025/stock-market-is-underpricing-downside-risks-of-the-tariff-rates-warns-expert-tariff-policy-nuances-are-far-more-important-than-the-one-big-beautiful-bill">Stock Market Is Underpricing &#8216;Downside Risks Of The Tariff Rates,&#8217; Warns Expert: Tariff Policy Nuances Are &#8216;Far More Important&#8217; Than The &#8216;One Big, Beautiful Bill&#8217;</a>
Why It Matters: According to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>, Tesla shares are trading at a price nearly 158.730 times its 2026 earnings. At the same time, the average <a href="https://www.benzinga.com/general/market-summary/25/05/45539236/tesla-is-6x-more-expensive-than-its-peers-and-the-most-overvalued-mag-7-stock-gordon-johnson-questions-fundamentals-as-elon-musk-shrugs-off-concerns">forward price-to-earnings</a> of its peers stood at 25.75 times, implying that Tesla was 6.16 times more expensive than its industry&#8217;s average. 
The shares were down 10.08% year-to-date, but it has returned by 36.01% just in the last month. TSLA was up 96.29% over the year. On Thursday, it ended 1.92% higher, and it advanced 1.40% in premarket on Friday.
Meanwhile, the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, were flat in premarket on Friday. The SPY was down 0.026% to $583.00, while the QQQ declined 0.099% to $513.52, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
TSLA has a consensus ‘hold&#8217; with a consensus price target of $292.93, according to the <a href="https://www.benzinga.com/quote/TSLA/analyst-ratings">27 analysts tracked by Benzinga</a>. The targets range from $19.05 to $500. Recent ratings by Mizuho, Wedbush, and Guggenheim suggest a $303.33 target, implying a 12.26% downside.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/quote/TSLA/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="388" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23061100/ANR-TESLA-1024x388.png" alt="" class="wp-image-925741" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23061100/ANR-TESLA-1024x388.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23061100/ANR-TESLA-300x114.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23061100/ANR-TESLA-768x291.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23061100/ANR-TESLA.png 1396w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Benzinga Edge Stock Rankings shows that Tesla had a stronger price trend over the short, medium, and long term. Its momentum ranking was solid, however, its value ranking was poor at the 8.76th percentile. The details of other metrics are <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">available here</a>.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"><img loading="lazy" decoding="async" width="1024" height="140" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23061035/EDGE-Tesla-new-1024x140.png" alt="" class="wp-image-925739" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23061035/EDGE-Tesla-new-1024x140.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23061035/EDGE-Tesla-new-300x41.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23061035/EDGE-Tesla-new-768x105.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23061035/EDGE-Tesla-new.png 1215w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/general/market-summary/25/05/45581555/growth-vs-value-expert-views-collide-on-the-impact-of-trumps-big-beautiful-bill">Growth Vs. Value: Expert Views Collide On The Impact Of Trump&#8217;s &#8216;Big, Beautiful&#8217; Bill</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors. Image Via Shutterstock

Analyst Color

Equities

Market Summary

Broad U.S. Equity ETFs

Futures

ETFs

General

TSLA Stock Jumps In Friday Premarket As Wedbush's Dan Ives Raises Price Target To $500, Citing 'Golden Age Of Autonomous' Vehicles

Needham analyst Laura Martin reiterates Nexxen International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEXN#NASDAQ">NEXN</a>) with a Buy and maintains $14 price target.

NEXN

Needham Reiterates Buy on Nexxen International, Maintains $14 Price Target

WestPark Capital analyst Curtis Shauger maintains Workday (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDAY#NASDAQ">WDAY</a>) with a Buy and raises the price target from $315 to $328.

WestPark Capital Maintains Buy on Workday, Raises Price Target to $328

U.S. stock futures were fluctuating on Friday after a mixed close on Thursday. Futures of major benchmark indices were mixed in premarket.
The week began with the market shrugging off <a href="https://www.benzinga.com/news/econ-s/25/05/45479078/moodys-downgrades-us-credit-rating-over-debt-deficit-concerns">Moody&#8217;s downgrade of the U.S. government debt</a>, however, it slipped later in the week as investors started assessing the impact of the new tax bill proposed by the Donald Trump administration, known as the &#8220;One, Big, Beautiful Bill.&#8221;
While the tax bill is expected to <a href="https://www.benzinga.com/markets/equities/25/05/45536595/big-beautiful-bill-will-explode-the-deficit-and-make-the-rich-richer-congressional-budget-office-estimates-4-income-fall-for-lowest-decile-of-americans-by-2033">add $3.8 trillion</a> to the U.S. debt as per Congressional Budget Office estimates, it was <a href="https://www.benzinga.com/news/25/05/45581297/trumps-big-beautiful-3-8-trillion-bill-squeaks-through-house-expert-says-it-will-boost-the-economy-in-the-short-term-but-worsen-deficitshttps://www.benzinga.com/news/25/05/45581297/trumps-big-beautiful-3-8-trillion-bill-squeaks-through-house-expert-says-it-will-boost-the-economy-in-the-short-term-but-worsen-deficits">passed by the U.S. House of Representatives</a> on Thursday by a 215-214 margin.
Meanwhile, the 10-year Treasury bond yielded 4.51% and the two-year bond was at 3.98%. The CME Group's FedWatch <a href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html">tool&#8217;</a>s projections show markets pricing a 94.7% likelihood of the Federal Reserve keeping the current interest rates unchanged in its June meeting.
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Futures</td>
<td>Change (+/-)</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>-0.07%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>-0.03%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>-0.04%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>0.13%</td>
</tr>
</tbody>
</table>
</figure>
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, rose in premarket on Friday. The SPY was up 0.16% to $584.05, while the QQQ advanced 0.21% to $515.09, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Cues From Last Session:
Sectoral moves drove a mixed day for U.S. stocks Thursday, as the Nasdaq Composite rose over 50 points while most S&amp;P 500 sectors closed lower.
Utilities, healthcare, and energy stocks saw the biggest losses. Conversely, consumer discretionary and communication services bucked the trend, finishing higher.
Economic data showed U.S. initial jobless claims falling to 227,000, beating estimates, and both S&amp;P Global services and manufacturing PMIs climbing to 52.3 in May.
Meanwhile, Advance Auto Parts Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AAP#NYSE">AAP</a>) shares surged 57% after strong Q1 results, and Vigil Neuroscience Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIGL#NASDAQ">VIGL</a>) skyrocketed 241% on news of a Sanofi acquisition.
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>0.28%</td>
<td>18,925.73</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>-0.044%</td>
<td>5,842.01</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>-0.0032%</td>
<td>41,859.09</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-0.049%</td>
<td>2,045.56</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts:
Jurrien Timmer, the director of global macro at Fidelity Investments, highlighted in an X post that the long end of the Treasury market was being ignored after the S&amp;P 500 recovered most of its decline below its 52-week high.
&#8220;There's an old saying that &#8216;nothing good ever happens after midnight,&#8217; and we could borrow that phrase and say that nothing good happens above a 5% yield,&#8221; he said, highlighting concerns about higher yields.
He added that &#8220;It's my strong hunch that the next chapter in this market cycle will be driven by rates, as term premia return to their historical pre-QE levels.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">With the S&amp;P 500 recovering most of its decline, little noticed has been the long end of the Treasury market, which is once again nearing the danger zone of 4.5-5.0% (10-year) as the term premium reaches a new cycle high of 74 bps. There's an old saying that "nothing good ever… <a href="https://t.co/riaAUGJOrn">pic.twitter.com/riaAUGJOrn</a>
&mdash; Jurrien Timmer (@TimmerFidelity) <a href="https://twitter.com/TimmerFidelity/status/1925617154612711785?ref_src=twsrc%5Etfw">May 22, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
&#8220;The budget discussion is fueling a lot of concern about deficits and debt levels rising over the long run,&#8221; said Kathy Jones, chief fixed income strategist at Schwab, who noted yields moving higher after the vote.
&#8220;The current proposal is expected to add anywhere from $3 trillion to $5 trillion to the accumulated debt over the next 10 years. The market appears to be voting against this bill and would like to see more fiscal restraint.&#8221;
The bill will now advance to the Senate, where it appears likely to face additional revisions.
&#8220;Congress has set a July target for a final bill to be signed into law, which could look very different than the current version. Consequently, we do not recommend taking actions based on the bill in its current form,&#8221; said Brian Therien of Edward Jones.
See Also: <a href="https://www.benzinga.com/money/how-to-trade-futures">How to Trade Futures </a>
Upcoming Economic Data
Here&#8217;s what investors will keep an eye on Friday:
<ul class="wp-block-list">
<li>Kansas City Fed President Jeff Schmid will speak at 9:35 a.m., new home sales data for April will be out by 10:00 a.m., and Federal Reserve Governor Lisa Cook will speak at noon ET.</li>
<li>On Sunday, Federal Reserve Chair Jerome Powell will deliver his commencement address at 2:40 p.m. ET.</li>
</ul>
Stocks In Focus:
<ul class="wp-block-list">
<li>Booz Allen Hamilton Holding Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAH#NYSE">BAH</a>) rose 3.09% in premarket on Friday as analysts expect it to report quarterly earnings of $1.59 per share on revenue of $3.03 billion, before the opening bell.</li>
<li>Buckle Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BKE#NYSE">BKE</a>) was up 1.45% as Wall Street expects it to report earnings before the opening bell. It is expected to post earnings of 69 cents per share on revenue of $268.06 million.</li>
<li>Frontline PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FRO#NYSE">FRO</a>) advanced 1.92% as analysts expect it to report quarterly earnings of 23 cents per share on revenue of $264.19 million, before the opening bell.</li>
<li>Autodesk Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADSK#NASDAQ">ADSK</a>) rose 3.32% after it reported better-than-expected first-quarter financial results, issued strong guidance for the second quarter, and raised its FY26 guidance.</li>
<li>Intuit Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTU#NASDAQ">INTU</a>) jumped 7.96% after reporting stronger-than-expected third-quarter financial results and raising its full-year guidance.</li>
<li>BloomZ Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLMZ#NASDAQ">BLMZ</a>) surged 43.88% and formed a strategic alliance with M-NEXT Holdings, owner of trading card retailer &#8220;Ryusei no Arashi.&#8221;</li>
<li>Aurinia Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUPH#NASDAQ">AUPH</a>) was 2.78% higher after it announced positive findings from a post-hoc analysis of its AURORA 1 Phase 3 study in lupus nephritis (LN) patients.</li>
<li>Hallador Energy Co. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HNRG#NASDAQ">HNRG</a>) dropped 10.25% as a major agreement, with a prominent global data center developer, was terminated on May 19, 2025.</li>
<li>Xerox Holdings Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XRX#NASDAQ">XRX</a>) slumped 8.79% after slashing its quarterly dividend by 75% to fund a $238 million synergy deal with Lexmark.</li>
<li>Sobr Safe Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOBR#NASDAQ">SOBR</a>) zoomed 18.84% after the company reported a year-over-year increase in first-quarter EPS and sales results.</li>
</ul>
Commodities, Gold, And Global Equity Markets:
Crude oil futures were trading lower in the early New York session by 0.49% to hover around $60.90 per barrel.
Gold Spot US Dollar rose 1.11% to hover around $3,331.29 per ounce. Its last record high stood at $3,500.33 per ounce. The U.S. Dollar Index spot was lower by 0.57% at the 99.3890 level.
Asian markets were mixed on Friday as South Korea's Kospi and China&#8217;s CSI 300 indices declined, whereas India's S&amp;P BSE Sensex, Japan's Nikkei 225, Australia's ASX 200, and Hong Kong's Hang Seng indices rose. European markets were also mixed in early trade.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45582025/stock-market-is-underpricing-downside-risks-of-the-tariff-rates-warns-expert-tariff-policy-nuances-are-far-more-important-than-the-one-big-beautiful-bill">Stock Market Is Underpricing &#8216;Downside Risks Of The Tariff Rates,&#8217; Warns Expert: Tariff Policy Nuances Are &#8216;Far More Important&#8217; Than The &#8216;One Big, Beautiful Bill&#8217; </a></li>
</ul>
Photo courtesy: godongphoto / Shutterstock.com

Treasuries

Economics

Pre-Market Outlook

ADSK

AUPH

BLMZ

HNRG

INTU

SOBR

VIGL

US Stocks Likely To Open On A Mixed Note: 'Nothing Good Happens Above A 5% Yield,' Says Expert

Press Releases

Legend Biotech to Host Investor Event During the 66th American Society of Hematology (ASH) Annual Meeting and Exposition

Legend Biotech Reports Third Quarter 2024 Results and Recent Highlights

CARVYKTI® Significantly Improved Minimal Residual Disease Negativity Compared to Standard of Care for Patients with Relapsed or Refractory Multiple Myeloma

Legend Biotech to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2024 Results

Legend Biotech Reports Fourth Quarter and Full Year 2024 Results and Recent Highlights

Legend Biotech to Host Investor Conference Call on First Quarter 2025 Results

Legend Biotech Reports First Quarter 2025 Results and Recent Highlights

Legend Biotech to Host Investor Event During the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

Legend Biotech Announces New Oncologic & Hematologic Therapeutic Developments at ASCO, EHA, and ASGCT

Comments

Legend Biotech

Notizie

Ultime notizie per Legend Biotech (NASDAQ:LEGN) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO